Glecaprevir/Pibrentasvir
M16-126
Phase 3 small_molecule completed
Quick answer
Glecaprevir/Pibrentasvir for Hepatitis C Virus (HCV) is a Phase 3 program (small_molecule) at AbbVie with 2 ClinicalTrials.gov record(s).
Program details
- Company
- AbbVie
- Indication
- Hepatitis C Virus (HCV)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed